NCT02336945|Completed
Loading search results
Sponsor study identifier
observational
146
1 country
7
Study Start
January 2015
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
July 2015
Actual (reported)Study Completion
July 2015
Actual (reported)This is a multi-center, prospective, non-pivotal, single arm, non-significant risk evaluation the Abbott Sensor Based Glucose Monitoring System - Pro across different stages of T2 diabetes management. This is a non-significant risk study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2015
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2015
Date type not reportedThis date has not been verified as actual or estimated.
January 9, 2015
Actual (reported)January 13, 2015
Actual (reported)July 2015
Actual (reported)July 2015
Actual (reported)Glucose variability as measured by AGP Interquartile Range, (IQR) obtained via System-Pro Sensor.
2 weeks
Assessment of ambulatory glucose profiles (AGPs) generated by the Software
2 weeks
Subjects with type 2 diabetes who meet one of the therapy conditions
Subjects will wear 2 glucose sensors while going about daily activities and adhering to establish diabetes treatment plan. This is not a treatment study.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Subjects with type 2 diabetes who meet one of the therapy groups
Unger Primary Care Medical Center & Catalina Research Institute
Chino, California, 91710, United States
Dr. Deanna Cheung
Long Beach, California, 90807, United States
University of California San Diego Veterns Affairs Medical Center
San Diego, California, 92161, United States
Henry Ford Medical Center
Detroit, Michigan, 48202, United States
St. Luke's Endocrinology and Diabetes
Kansas City, Missouri, 64111, United States
Duke Southern Regional AHEC
Fayetteville, North Carolina, 28304, United States
Diabetes America- Pearland
146 participants (actual enrollment reported by the registry).
First Submitted
January 9, 2015
First Posted
January 13, 2015
Study Start
January 2015
Date type not reportedThis date has not been verified as actual or estimated.
A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes
Contact the study team to confirm eligibility.
Pearland, Texas, 77584, United States
Primary Completion
July 2015
Actual (reported)Study Completion
July 2015
Actual (reported)Last Updated
January 24, 2017
Record last verified: 2015-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: